In this video interview, Umesh Chaudhari, executive medical director and global program head of the C5 programs at Regeneron, ...

Oruka Therapeutics presents positive interim phase 1 results for ORKA-001 at EADV Congress: Menlo Park, California Thursday, September 18, 2025, 18:00 Hrs [IST] Oruka Therapeutics ...

Panelists discuss how the BE OPTIMAL study enrolled biologic-naive patients, whereas BE COMPLETE enrolled TNF inhibitor-inadequate responders. Both populations showed similar response rates despite ...

Borderlands 4's reimagined Ultimate Vault Hunter Mode is a mixed bag of successes and missteps that may undermine the mode's true potential.

EVERLAST-A Phase 2a trial enrollment ongoing with data expected 2H 2026 MENLO PARK, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology ...

This technology could be used to promote timely lifestyle changes or to design health policies, but experts warn of its ...

The Company plans to use the proceeds to accelerate the development of Teverelix, a next generation GnRH Antagonist, as a ...

Researchers executed a phase 1b study to determine the safety and efficacy of venetoclax combined with a 7+3 chemotherapy regimen in treating acute myeloid leukemia.

Good morning, ladies and gentlemen, and welcome to aTyr Pharma conference call to review the top line results for the Phase III EFZO-FIT study of efzofitimod in pulmonary sarcoidosis. [Operator ...

Guardians of the Galaxy — Mission: Breakout broke into the Best of OC lineup in 2025 for the first time since the drop tower ride debuted in 2017. The re-skinned Guardians attraction in Disney ...

A new randomized controlled trial protocol from the Netherlands will test whether altering the texture, and thus the eating ...

Exergaming may positively impact gray matter and white matter in the brain, and these brain changes may be linked to ...